Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

Sarah E Thomas; Marieke M B Seyger; Josje E Mangnus; Marisol E Otero; Antoni H Gostynski; Marcellus D Njoo; Paul M Ossenkoppele; Inge M Haeck; Judith H J Hendricksen-Roelofzen; John E M Körver; Sharon R P Dodemont; Ron A Tupker; Maartje A M Berends; Lizelotte M J T Weppner-Parren; Romy R M C Keijsers; Annet M Oostveen; Bas Peters; Roland Mommers; Martijn B A van Doorn; Milan Tjioe; Wendelien R Veldkamp; Astrid L A Kuijpers; Marloes M Kleinpenning; Elke M G J de Jong; Juul M P A van den Reek

doi:10.1007/s40257-024-00868-x

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

Sarah E Thomas^*, Marieke M B Seyger, Josje E Mangnus, Marisol E Otero, Antoni H Gostynski, Marcellus D Njoo, Paul M Ossenkoppele, Inge M Haeck, Judith H J Hendricksen-Roelofzen, John E M Körver, Sharon R P Dodemont, Ron A Tupker, Maartje A M Berends, Lizelotte M J T Weppner-Parren, Romy R M C Keijsers, Annet M Oostveen, Bas Peters, Roland Mommers, Martijn B A van Doorn, Milan TjioeWendelien R Veldkamp, Astrid L A Kuijpers, Marloes M Kleinpenning, Elke M G J de Jong, Juul M P A van den Reek

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	685-688
Number of pages	4
Journal	American journal of clinical dermatology
Volume	25
Issue number	4
Early online date	27 May 2024
DOIs	https://doi.org/10.1007/s40257-024-00868-x
Publication status	Published - Jul 2024

Access to Document

10.1007/s40257-024-00868-x

Cite this

Thomas, S. E., Seyger, M. M. B., Mangnus, J. E., Otero, M. E., Gostynski, A. H., Njoo, M. D., Ossenkoppele, P. M., Haeck, I. M., Hendricksen-Roelofzen, J. H. J., Körver, J. E. M., Dodemont, S. R. P., Tupker, R. A., Berends, M. A. M., Weppner-Parren, L. M. J. T., Keijsers, R. R. M. C., Oostveen, A. M., Peters, B., Mommers, R., van Doorn, M. B. A., ... van den Reek, J. M. P. A. (2024). Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment. American journal of clinical dermatology, 25(4), 685-688. https://doi.org/10.1007/s40257-024-00868-x

@article{37a885da47b34c76a5e79ad3dfa30dc6,

title = "Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment",

author = "Thomas, {Sarah E} and Seyger, {Marieke M B} and Mangnus, {Josje E} and Otero, {Marisol E} and Gostynski, {Antoni H} and Njoo, {Marcellus D} and Ossenkoppele, {Paul M} and Haeck, {Inge M} and Hendricksen-Roelofzen, {Judith H J} and K{\"o}rver, {John E M} and Dodemont, {Sharon R P} and Tupker, {Ron A} and Berends, {Maartje A M} and Weppner-Parren, {Lizelotte M J T} and Keijsers, {Romy R M C} and Oostveen, {Annet M} and Bas Peters and Roland Mommers and {van Doorn}, {Martijn B A} and Milan Tjioe and Veldkamp, {Wendelien R} and Kuijpers, {Astrid L A} and Kleinpenning, {Marloes M} and {de Jong}, {Elke M G J} and {van den Reek}, {Juul M P A}",

year = "2024",

month = jul,

doi = "10.1007/s40257-024-00868-x",

language = "English",

volume = "25",

pages = "685--688",

journal = "American journal of clinical dermatology",

issn = "1179-1888",

publisher = "Adis",

number = "4",

}

Thomas, SE, Seyger, MMB, Mangnus, JE, Otero, ME, Gostynski, AH, Njoo, MD, Ossenkoppele, PM, Haeck, IM, Hendricksen-Roelofzen, JHJ, Körver, JEM, Dodemont, SRP, Tupker, RA, Berends, MAM, Weppner-Parren, LMJT, Keijsers, RRMC, Oostveen, AM, Peters, B, Mommers, R, van Doorn, MBA, Tjioe, M, Veldkamp, WR, Kuijpers, ALA, Kleinpenning, MM, de Jong, EMGJ & van den Reek, JMPA 2024, 'Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment', American journal of clinical dermatology, vol. 25, no. 4, pp. 685-688. https://doi.org/10.1007/s40257-024-00868-x

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment. / Thomas, Sarah E; Seyger, Marieke M B; Mangnus, Josje E et al.
In: American journal of clinical dermatology, Vol. 25, No. 4, 07.2024, p. 685-688.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab

T2 - Evaluating Real-World Outcomes in Psoriasis Treatment

AU - Thomas, Sarah E

AU - Seyger, Marieke M B

AU - Mangnus, Josje E

AU - Otero, Marisol E

AU - Gostynski, Antoni H

AU - Njoo, Marcellus D

AU - Ossenkoppele, Paul M

AU - Haeck, Inge M

AU - Hendricksen-Roelofzen, Judith H J

AU - Körver, John E M

AU - Dodemont, Sharon R P

AU - Tupker, Ron A

AU - Berends, Maartje A M

AU - Weppner-Parren, Lizelotte M J T

AU - Keijsers, Romy R M C

AU - Oostveen, Annet M

AU - Peters, Bas

AU - Mommers, Roland

AU - van Doorn, Martijn B A

AU - Tjioe, Milan

AU - Veldkamp, Wendelien R

AU - Kuijpers, Astrid L A

AU - Kleinpenning, Marloes M

AU - de Jong, Elke M G J

AU - van den Reek, Juul M P A

PY - 2024/7

Y1 - 2024/7

U2 - 10.1007/s40257-024-00868-x

DO - 10.1007/s40257-024-00868-x

M3 - Comment/Letter to the editor

SN - 1179-1888

VL - 25

SP - 685

EP - 688

JO - American journal of clinical dermatology

JF - American journal of clinical dermatology

IS - 4

ER -